Last Updated on
Charlotte Figi, the namesake of a Colorado CBD company who became a symbol for the therapeutic potential of cannabidiol and medical cannabis, has reportedly died from complications associated with COVID-19, the illness caused by the coronavirus pandemic.
Charlotte’s death was announced late Tuesday in a Facebook post by a family friend. No time or location of death was provided.
Early Wednesday, the foundation co-founded by Paige Figi, Charlotte’s mother, said Charlotte’s death occurred on Tuesday and was linked to the coronavirus. She was 13.
“It is with a heavy heart that we write to let you know that Charlotte Figi passed away this afternoon from COVID-19 complications,” the Realm of Caring Foundation, a CBD research and advocacy group, wrote on Facebook.
The post has since been edited to remove the attribution of her death to COVID-19 complications.
According to a report from the Colorado Sun, Figi had written previous Facebook posts about a serious illness that struck all the members of her family and sent Charlotte to the hospital, but she never explicitly mentioned COVID-19. Figi wrote at one point that the family had been unable to get tested for the illness, the Sun reported.
Charlotte had suffered from seizures brought on by a rare form of epilepsy known as Dravet syndrome that were said to have drastically subsided after her mother started her on therapy with a high-cannabidiol strain of medical cannabis.
That strain was bred on a farm in Colorado by Joel Stanley and his brothers, who named their company Charlotte’s Web Holdings for her.
We are not the original authors of this article. This content was republished from HempIndustryDaily.com.